Infanrix (DTPa) inj. susp. i.m. vial

Țară: Belgia

Limbă: engleză

Sursă: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Ingredient activ:

Tetanus Toxoid >= 40 IU/dose; Bordetella pertussis Toxoid (PT) 25 µg/dose; Bordetella pertussis Filamentous Hemagglutinin (FHA) 25 µg/dose; Bordetella pertussis Pertactin 8 µg/dose; Diphtheria Toxoid (DT) >= 30 IU/dose

Disponibil de la:

GlaxoSmithKline Biologicals SA-NV

Codul ATC:

J07AJ52

INN (nume internaţional):

Diphteria Antigen, Adsorbed; Tetanus Toxoid Adsorbed; Bordetella Pertussis

Forma farmaceutică:

Suspension for injection in pre-filled syringe

Compoziție:

Diphteria Antigen, Adsorbed; Tetanus Toxoid Adsorbed; Bordetella Pertussis

Calea de administrare:

Intramuscular use

Zonă Terapeutică:

Pertussis, Purified Antigen, Combinations with Toxoids

Rezumat produs:

CTI code: 169312-01 - Pack size: 1 dose (0.5 (0.5) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 169312-02 - Pack size: 10 x 1 dose (0.5 (0.5) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 169312-03 - Pack size: 25 x 1 dose (0.5 (0.5) - Commercialisation status: NO - Delivery mode: Medical prescription

Statutul autorizaţiei:

Commercialised: No

Data de autorizare:

1995-05-11